Acute Ischemic Stroke Program - eV3

Clinical Education Comprehensive Stroke Portfolio
STROKE CENTERS OF EXCELLENCE PROGRAM
We believe in answering the needs of healthcare professionals involved in
revascularization by building peer-to-peer networks.
Our goal is to develop meaningful opportunities in sharing best practices
through our renowned Stroke Centers of Excellence and to build interactions
between stroke units around the world.
This program is run in partnership with world class European stroke centers
using the most advanced tools, protocols and techniques. The faculty includes
world-renowned neurologists and interventional neuroradiologists from:
• Karolinska Institute, Stockholm, Sweden
• Inselspital, Bern, Switzerland
• Gui-de-Chauliac, Montpellier, France
Course eduCation
objeCtives
• Considerations for
Organizing a Stroke
Team and a Stroke Unit
• Develop Acute Ischemic
Stroke Protocols
• Improve Patient
Selection and
Treatment Parameters
• Discuss Acute Ischemic
Stroke Treatment
Evolution and Status
• Case Reviews and
Complications
• Hands-on Experience
Solitaire FR Revascularization Device
Catalog
Number
Recommended
Vessel Diameter
(mm)
Minimum
Micro Catheter
ID (in)
Push Wire
Length
(cm)
Diameter
(mm)
Usable
Length
(mm)
Total
Length
(mm)
Distal
Markers
SFR-4-15 2.0 – 4.0 0.021 180 4 15 26 3 1
SFR-4-20 2.0 – 4.0 0.021 180 4 20 31 3 1
SFR-6-20 3.0 – 5.5 0.027 180 6 20 31 4 1
SFR-6-30 3.0 – 5.5 0.027 180 6 30 42 4 1
Cello Balloon Guide Catheter
Catalog
Number
Product Name
Conformable
Sheath (F)
Tip Length
(mm)
Balloon
Length (mm)
ID (mm)
Effective
Length (cm)
Proximal
Markers
Total
Length
(cm)
1610060 Cello 6F+ 7 3 7 1.30 (0.051 in) 102 110
1610070 Cello 7F+ 8 3 7 1.75 (0.069 in) 102 110
1610080 Cello 8F 8 3 10 1.90 (0.075 in) 95 102
1610090 Cello 9F 9 3 10 2.15 (0.085 in) 92 100
Rebar 18 Reinforced Micro Catheter
Catalog
Number (1/box)
105-5081-153 *C
OD (F) Distal ID (in)
Total Length
(cm)
Usable Length
(cm)
Max.
Guidewire (in)
2.8-2.3 0.021 153 153 0.018
105-5081-130 2.8-2.3 0.021 135 130 0.018
105-5083-153 2.8-2.3 0.021 158 153 0.018
Rebar 27 Reinforced Micro Catheter
Catalog
Number (1/box)
OD (F) Distal ID (in)
Total Length
(cm)
Usable Length
(cm)
*Dual Marker Band.
Max.
Guidewire (in)
105-5082-130 2.8-2.8 0.027 135 130 0.018
105-5082-145 2.82.8 0.027 150 145 0.018
SOLITAIRE FR DEVICE OFFERS
OPTIMIzED OUTCOMES
• Easy-to-Use and Single-Operator
• Short Procedure Time
• Fast Flow Restoration and Reliable Clot Removal
• Optimized Performance with State-of-the-Art
Covidien Products
Diameter
Distal Markers
Total Length
Retrieval Zone
Solitaire FR
Device Stroke Kit
Configurations
Solitaire FR Device Stroke Kit 4x15
Solitaire FR device 4mm x 15mm
Cello 8F balloon guide catheter8 Rebar 18 micro catheter
Solitaire FR Device Stroke Kit 4x20
Solitaire FR device 4mm x 20mm
Cello 8F balloon guide catheter8 Rebar 18 micro catheter
Solitaire FR Device Stroke Kit 6x20
Solitaire FR device 6mm x 20mm
Cello 8F balloon guide catheter8 Rebar 27 micro catheter
Solitaire FR Device Stroke Kit 6x30
Solitaire FR device 6mm x 30mm
Cello 8F balloon guide catheter8 Rebar 27 micro catheter
Push Wire
Proximal Marker
Availability of product may vary by region. Please contact your Covidien sales representative regarding availability in your country.
COVIDIEN, COVIDIEN with logo, and Covidien logo are US and internationally registered trademarks of Covidien AG.
Trademark of a Covidien company.* Trademark of its respective owner. © 2012 Covidien. 115763-001 (A) APR/12 – Intl.
106-108 rue La Boétie
75008 Paris
France
+33 156 88 59 10 [t]
+33 156 88 59 11 [f]
www.covidien.com
• Clinical Studies
• Clinical Education
• Comprehensive Stroke Portfolio
Acute Ischemic Stroke Program
Solitaire FR
Revascularization Device

Solitaire FR Revascularization Device Clinical Studies
Restore Flow
Unique design.
Fast flow restoration.
The Solitaire FR device’s self-expanding
design creates a simple, single-operator
procedure. 1
Retrieve Clot
Maximize clot retrieval.
Minimize procedure time.
Solitaire FR device with Parametric
Design provides multiple planes of
clot contact to enhance capture. 2
Revive
Neurological Tissue 4
Next generation technology.
Revolutionary clinical results.
Solitaire FR revascularization device is the
most effective 5 mechanical thrombectomy
device combining the ability to immediately
restore blood flow, administer medical
therapy and retrieve clot in patients
experiencing acute ischemic stroke.
REVASCULARIzATION RATE
VESSEL WALL
Clot
Solitaire FR
Device deployed
VESSEL WALL
Depiction of a 4x20 Solitaire FR Device in a vessel.
96.0%
68.5%
Retrospective Study (TICI≥2a) SWIFT (TIMI≥2)
Radial Force (N/mm)
mm 2
RADIAL FORCE 3
0.08
0.06
0.04
0.02
0
CELL AREA 3
0.12
0.1
0.08
0.06
0.04
0.02
Deployment Retrieval
0.71 1 1.5 2 2.5
Constrained Diameter (mm)
Based on an average of N=3 4x20 Solitaire FR Revascularization Devices
Maximized radial force when deployed within
occlusion to facilitate fast flow restoration.
0.095mm 2
81% of Area Maintained
0.1115mm 2
Based on an average of N=2 4x20 Solitaire 2.25mm
0.0
Cell Area in Constrained Tube.
FR Revascularization Devices.
2 3.0mm2 Parametric Design preserves cell-size over
varying vessel diameters which enhances clot
capture and retrieval.
3
3.5 4
FAST FLOW RESTORATION
Flow restoration to the MCA upon deployment of
the Solitaire FR device.
WALL APPOSITION 3
NEUROLOGICAL OUTCOMES MORTALITy RATE
54.6%
Retrospective Study
(mRS≤2)
36.0%
SWIFT
(mRS≤2)
58.2%
SWIFT
(Good Neurological
Outcomes)
Good neurological outcome defined as mRS ≤ 2, or equal to the prestroke
mRS if the prestroke mRS was higher than 2, or NI HSS score improvement
of 10 points or more.
Solitaire FR Revascularization
Device in a 3mm Vessel.
An optimal balance of navigability, wall-apposition,
and clot retention.
20.5%
17.2%
Retrospective Study SWIFT
Solitaire FR With Intention
For Thrombectomy (SWIFT) 7
Retrospective
Study 7
Principal Investigators (PI) J.L. Saver, U.S.A. N/A
Number of Patients
113
(58 Solitaire FR, 55 MERCI * )
Solitaire FR Thrombectomy for Acute
Revascularization (STAR) 7
V. Mendes Pereira, Switzerland
J. Gralla, Switzerland
reFerenCes
1. Design Specification: PS08-001F. 2. Covidien Testing Data: FD2601A. 3. FD2815: Competitive Device Test Plan---Flow Restoration Device. 4. SolitairetM FR Retrospective Study 5. The Solitaire FR
Revascularization Device is superior to the Merci Retrieval System* in achieving arterial recanalization of the occluded target vessel without any presence of symptomatic intracranial hemorrhage in the
Solitaire FR With Intention For Thrombectomy (SWIFT) Study SWIFT IDE # GO90082 FD2923. 6. Symptomatic Intracerebral Hemorrhage 7. Corelab reviewed 8. The CellotM balloon guide catheter may not
be available for distribution in your country.
INITIAL ANGIOGRAM AFTER INITIAL DEPLOYMENT
For general inquiries or to learn more about
Physician Workshops and Centers of Excellence,
please email stroke@covidien.com
141
200
(enrolling)
Baseline NIHSS 17.3 18 (8-30)
Recanalization Rate
(TIMI≥2)
Revascularization Rate
(TICI≥2b)
68.5% - N/A
- 85% Primary Endpoint
mRS≤2 at 90 days 36.3% 54.6% Secondary Endpoint
Mortality at 90 days 17.2% 20.5% N/A
Device Related Adverse Events 8.6% 0.7% N/A
SICH 6 1.7% 4% N/A
Solitaire FR With Intention For Thrombectomy (SWIFT): The purpose of this study is to demonstrate substantial equivalence of the Solitaire FR
revascularization device with a legally marketed device, Merci Retrieval System * .
Retrospective Study: The purpose of this study is to provide safety and efficacy data on the Solitaire FR device when used as a first choice device in
real practice in revascularization of patients with acute ischemic stroke.
Solitaire FR Thrombectomy for Acute Revascularization (STAR): The purpose of this study is to evaluate the safety and efficacy of the Solitaire FR device in subjects requiring mechanical thrombectomy when used to its Instructions For Use (IFU), in real life practice.
Case study images provided with permission by Prof. Andersson, Karolinska Hospital, Helsinki, Sweden.